The United States government has agreed to pay $5.29 billion for 10 million courses of Pfizer’s experimental COVID 19 antiviral pill as the country rushes to secure new oral treatments to manage the disease. According to Reuters, this deal is for around twice as many treatment courses as those Merck …
Read More »